Nobilis Health Corp. is a full-service healthcare development and management company headquartered in Houston, Texas. Established in 2007, the company specializes in owning and managing healthcare facilities, including ambulatory surgery centers (ASCs) and acute-care hospitals, primarily in Texas and Arizona. Nobilis Health is dedicated to providing superior medical care, enhancing patient satisfaction, and reducing healthcare delivery costs. The company employs a unique direct-to-consumer marketing strategy to attract patients for specific procedures performed by local physicians at its centers.
Strategically, Nobilis Health focuses on expanding its network of healthcare facilities and enhancing its in-network revenue streams. The company has pursued growth through acquisitions, such as the 2017 purchase of a majority stake in Elite Surgical Affiliates' portfolio, which included three ASCs and one surgical hospital in the Houston area. This acquisition added 76 physician partners and increased the company's in-network patient volume. Additionally, Nobilis Health acquired DeRosa Medical, a primary care practice in Arizona, to strengthen its continuum of care and expand its clinical integration network.
In 2017, Nobilis Health reported revenues of approximately $300 million, reflecting a 5% increase from the previous year. The company's growth has been supported by strategic acquisitions and an expanded network of facilities. In 2018, Nobilis Health received final approval to list its common shares on the NEO Exchange, becoming the first corporation to list on both a U.S.-based stock exchange and NEO.
Nobilis Health's technological platform includes proprietary direct-to-consumer marketing technology that effectively guides patients from awareness to commitment. This integrated marketing approach distinguishes Nobilis from other surgical centers and treatment facilities.
The leadership team has experienced changes over the years. In November 2017, Harry Fleming was appointed CEO and Chairman of the Board, succeeding Dr. Donald L. Kramer, who retired from the Board. In December 2018, James Springfield was appointed CEO, replacing Fleming. In May 2019, Springfield resigned, and Kenneth Efird, who had been serving as President, also resigned in September 2019.
The healthcare services industry is highly competitive, with key players such as AMSURG, HCA Healthcare, Tenet Healthcare, and Community Health Systems. These competitors operate extensive networks of hospitals and ASCs, offering a wide range of medical services. Nobilis Health differentiates itself through its direct-to-consumer marketing strategy and focus on specific procedures performed by local physicians.
Nobilis Health has engaged in strategic collaborations to enhance its market position. In 2015, the company entered into a strategic alliance with Renew Spinal Care, LLC, allowing Renew to perform procedures in Nobilis facilities and share research, development, and technology. This alliance also granted Nobilis the right of first refusal to become the exclusive health facility for Renew's procedures in new markets.
Operationally, Nobilis Health's competitive advantages include its proprietary marketing technology, strategic acquisitions, and partnerships that expand its network and service offerings. The company's focus on in-network revenue and clinical integration positions it to navigate the evolving healthcare landscape effectively.
Looking ahead, Nobilis Health aims to continue expanding its network through strategic acquisitions and partnerships, enhancing its technological capabilities, and focusing on in-network revenue growth. The company's strengths in marketing and facility management position it to capitalize on opportunities in the healthcare sector.
For more information, visit Nobilis Health's official website at nobilishealth.com.
Market Research
